Insight Molecular Diagnostics Inc

Research Insight Molecular Diagnostics Inc (IMDX) on Bullrun: market cap USD 175.01M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIMDX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 175.01M
• Financial periodFY2025
• RevenueUSD 4.06M
• Revenue growth115.6%
• Net income-USD 50.22K
• Free cash flow-USD 25.37M
• Gross margin56.7%

Valuation Snapshot

latest market cap is USD 175.01M.

About Insight Molecular Diagnostics Inc

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies.

Frequently asked questions

What is Insight Molecular Diagnostics Inc's market cap?

Insight Molecular Diagnostics Inc's market capitalization is USD 175.01M.

What does Insight Molecular Diagnostics Inc do?

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests.